We only have this paper's title and publication details.
Read it at the sourceThis review discusses the biological activity of secondary metabolites and their potential as antineoplastic drugs derived from actinomycetes, suggesting therapeutic possibilities.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: